Blockchain Registration Transaction Record

Cybin CMO to Present at Cantor Healthcare Conference on Mental Health Innovations

Cybin CMO Amir Inamdar to present at Cantor Healthcare Conference on Sept 5, 2025. Company developing breakthrough psychedelic treatments for depression and anxiety disorders with FDA designation.

This development matters because mental health disorders affect hundreds of millions worldwide, with current treatments often providing inadequate relief or causing significant side effects. Cybin's work represents a potential paradigm shift in psychiatric care, offering hope for more effective and durable treatments for conditions like depression and anxiety that impact nearly one in five adults. The company's FDA Breakthrough Therapy designation indicates the significant potential of their approach, which could transform how mental health conditions are treated and improve quality of life for millions suffering from these debilitating disorders.